`
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`___________________
`
`NEPTUNE GENERICS, LLC,
`APOTEX INC., APOTEX CORP.,
`TEVA PHARMACEUTICALS USA, INC.,
`and FRESENIUS KABI USA, LLC,
`
`PETITIONERS,
`
`V.
`
`ELI LILLY & COMPANY,
`
`PATENT OWNER.
`
`___________________
`
`Case IPR2016-002401
`Patent 7,772,209
`___________________
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICE
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`1 Cases IPR2016-01191 and IPR2016-01343 have been joined with the instant
`proceeding.
`
`
`
`Neptune Generics, LLC, the Petitioner, respectfully submits this Updated
`
`Mandatory Notice pursuant to 37 C.F.R. § 42.8(b)(1) to update real parties-in-
`
`interest.
`
`I.
`
`37 C.F.R. § 42.8(b)(1) – Real Parties-In-Interest
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), Petitioner certifies the following
`
`information: Neptune Generics, LLC, Niagara FundingCo, LLC, GKC Partners II,
`
`LP, GKC General Partner II, LLC, Burford Capital Investment Management LLC,
`
`Justitia Ireland Investments DAC, Burford Capital Holdings (UK) Limited and
`
`Burford Capital Limited are the real parties in interest (collectively, “RPI”).
`
`Neptune Generics, LLC, a New York limited liability company, is 100% owned by
`
`Niagara FundingCo, LLC, a New York limited liability company, which itself is
`
`100% owned by GKC Partners II, LP, a Delaware limited partnership. GKC
`
`General Partner II, LLC, a Delaware limited liability company, is the general
`
`partner of, and Burford Capital Investment Management LLC, a Delaware limited
`
`liability company, is the investment manager to, GKC Partners II, LP. GKC
`
`General Partner II, LLC is 100% owned by Justitia Ireland Investments DAC, a
`
`Designated Activity Company organized and existing under the laws of Ireland,
`
`which is 100% owned by Burford Capital Holdings (UK) Limited, a company
`
`incorporated under the laws of England and Wales. Burford Capital Holdings
`
`(UK) Limited is 100% owned by Burford Capital Limited, a company incorporated
`
`
`
`1
`
`
`
`under the laws of Guernsey. No other person (including any investor, limited
`
`partner, or member or any other person in any of Neptune Generics, LLC, Niagara
`
`FundingCo, LLC, GKC Partners II, LP, GKC General Partner II, LLC, Burford
`
`Capital Investment Management LLC, Justitia Ireland Investments DAC, Burford
`
`Capital Holdings (UK) Limited or Burford Capital Limited) has authority to direct
`
`or control (i) the timing of, filing of, content of, or any decisions or other activities
`
`relating to this Petition or (ii) any timing, future filings, content of, or any
`
`decisions or other activities relating to the future proceedings related to this
`
`Petition. All of the costs associated with this Petition are to be borne by Neptune
`
`Generics, LLC, Niagara FundingCo, LLC, GKC Partners II, LP, GKC General
`
`Partner II, LLC, Burford Capital Investment Management LLC, Justitia Ireland
`
`Investments DAC, Burford Capital Holdings (UK) Limited and Burford Capital
`
`Limited.
`
`
`
`2
`
`
`
`Respectfully Submitted,
`
`/Sarah E. Spires/
`Sarah E. Spires (Reg. No. 61,501)
`SKIERMONT DERBY LLP
`2200 Ross Ave., Ste. 4800W
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6601
`Lead Counsel for Petitioner
`
`Dr. Parvathi Kota (Reg. No. 65,122)
`Paul J. Skiermont (pro hac vice
`requested)
`SKIERMONT DERBY LLP
`2200 Ross Ave., Ste. 4800W
`Dallas, Texas 75201
`P: 214-978-6600/F: 214-978-6621
`
`Mieke K. Malmberg (pro hac vice
`requested)
`SKIERMONT DERBY LLP
`800 Wilshire Boulevard
`Los Angeles, CA 90017
`P: 213-788-4500/F: 213-788-4545
`Back-Up Counsel for Petitioner
`
`
`
`3
`
`January 12, 2017
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Patent Owner a true and correct copy of the foregoing Petitioner’s
`
`Updated Mandatory Notice Pursuant to 37 C.F.R. § 42.8, by electronic means on
`
`January 12, 2017 at the following addresses of record:
`
`Dov P. Grossman (Reg. No. 72,525)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth St. NW
`Washington, DC 20005
`Direct Phone: 202-434-5812
`Facsimile: 202-434-5029
`dgrossman@wc.com
`Lead Counsel for Patent Owner
`
`Adam L. Perlman (pro hac vice)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth St. NW
`Washington, DC 20005
`Direct Phone: 202-434-5244
`Facsimile: 202-434-5029
`aperlman@wc.com
`Back-Up Counsel for Patent Owner
`
`John C. Demeter (Reg. No. 30,167)
`ELI LILLY AND COMPANY
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-3785
`Facsimile: 317-276-3861
`Demeter_john_c@lilly.com
`Back-Up Counsel for Patent Owner
`
`
`
`
`
`David M. Krinsky (Reg. No. 72,339)
`WILLIAMS & CONNOLLY LLP
`725 Twelfth St. NW
`Washington, DC 20005
`Direct Phone: 202-434-5338
`Facsimile: 202-480-8302
`dkrinsky@wc.com
`Back-Up Counsel for Patent Owner
`
`James P. Leeds (Reg. No. 35,241)
`ELI LILLY AND COMPANY
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-1667
`Facsimile: 317-277-6534
`leeds_james@lilly.com
`Back-Up Counsel for Patent Owner
`
`John D. Polivick (Reg. No. 57,926)
`RAKOCZY MOLINO
`MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: 312-527-2157
`Fax: 312-527-4205
`jpolivick@rmmslegal.com
`Lead Counsel for Petitioner Apotex
`
`
`
`
`
`Patrick C. Kilgore (Reg. No. 69,131)
`RAKOCZY MOLINO
`MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: 312-527-2157
`Fax: 312-527-4205
`pkilgore@rmmslegal.com
`Back-Up Counsel for Petitioner Apotex
`
`Mark D. Schuman (Reg. No. 31,197)
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST AND SCHUMAN
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Tel: 612-436-9600
`Fax: 612-436-9605
`mschuman@carlsoncaspers.com
`Back-Up Counsel for Petitioner Teva
`
`
`
`Respectfully Submitted,
`
`/Sarah E. Spires/
`Sarah E. Spires (Reg. No. 61,501)
`
`Lead Counsel for Petitioner
`
`
`
`
`
`Deanne M. Mazzochi (Reg. No. 50,158)
`RAKOCZY MOLINO
`MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: 312-527-2157
`Fax: 312-527-4205
`dmazzochi@rmmslegal.com
`Back-Up Counsel for Petitioner Apotex
`
`Gary J. Speier (Reg. No. 45,458)
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST AND SCHUMAN
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Tel: 612-436-9600
`Fax: 612-436-9605
`gspeier@carlsoncaspers.com
`Lead Counsel for Petitioner Teva
`
`Cynthia Lambert Hardman
`(Reg. No. 45,458)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, New York 10018-1405
`Tel: 212-813-8800
`Fax: 212-355-3333
`chardman@goodwinprocter.com
`Back-Up Counsel for Petitioner Teva
`
`Dated: January 12, 2017